Beyond HeLa: Teaching the Henrietta Lacks Case as a Cornerstone of Research Ethics
BioethicsMedical HistoryLegal Ethics

Beyond HeLa: Teaching the Henrietta Lacks Case as a Cornerstone of Research Ethics

DDr. Eleanor Grant
2026-04-17
21 min read
Advertisement

A classroom-ready guide to Henrietta Lacks, Novartis, informed consent, biospecimens, patient rights, and modern bioethics reforms.

Beyond HeLa: Teaching the Henrietta Lacks Case as a Cornerstone of Research Ethics

The Henrietta Lacks story is more than a famous episode in medical history; it is a living classroom for understanding informed consent, biospecimens, research ethics, and the uneven distribution of profits from biomedical discovery. The recent Novartis settlement with the Lacks estate adds a modern legal and moral dimension: it reminds students that questions first raised in 1951 did not end when HeLa cells transformed science. For educators building a bioethics curriculum, this case offers a rare opportunity to connect patient rights, law, science, and social justice in one coherent lesson. It also helps learners see why modern reforms around human tissue, privacy, and governance exist at all.

Because this topic sits at the intersection of history and policy, it benefits from the same careful sourcing used in archival work. If you are creating a classroom module, consider pairing this guide with a lesson on primary sources in historical research, a discussion of evidence-based civic literacy, and an activity on how institutions communicate accountability. The Henrietta Lacks case is especially powerful because it can be taught from multiple angles: as a medical breakthrough, as a civil rights story, and as a legal case study about who benefits when human materials become scientific infrastructure.

Why the Henrietta Lacks Case Still Matters

A story about science, dignity, and power

Henrietta Lacks was a Black woman treated for cervical cancer at Johns Hopkins in 1951. Cells taken from her tumor were cultured without her knowledge or permission, and those cells—later known as HeLa—became one of the most important tools in modern biomedical research. That scientific value is undeniable, but the ethical cost is equally real. Students should understand that the problem was not simply that cells were used; it was that the patient whose body produced them was not meaningfully asked, informed, or compensated.

This makes the story a foundational case for discussing patient rights. It raises questions that still shape hospital consent forms, university review boards, tissue banks, and commercial partnerships. For teachers, the case works well because it avoids abstraction: students can immediately see how an act performed in a clinical setting can generate scientific gain, market value, and legal dispute. It also gives language to a broader issue in research ethics—how easily marginalized patients can be excluded from the benefits of the work done on or with their bodies.

From laboratory discovery to public reckoning

HeLa cells enabled advances in virology, vaccine development, cancer biology, genetics, and cell culture techniques. Yet for decades, the family had limited visibility into how those cells were being used, how widely they were distributed, and how much value they generated. That imbalance made the case a centerpiece of bioethics, particularly when institutions and media outlets began asking whether scientific progress can ever justify silence, deception, or the erasure of the source person.

The Novartis settlement is important not because it resolves every question, but because it confirms the issue is still active in the present tense. A pharmaceutical company that settles with the estate signals that the moral and legal legacy of the case has matured into a discussion about restitution, governance, and the corporate responsibilities of firms that benefit from long chains of biological contribution. In class, that is a useful pivot point: students can compare the historical treatment of Henrietta Lacks with the expectations placed on research institutions today.

Suggested classroom framing

A strong lesson begins with three prompts. First: What did Henrietta Lacks and her family know, and what were they not told? Second: Who profited from HeLa cells, and why does profit matter ethically even when the science is valuable? Third: What would meaningful consent look like if the same event happened today? These questions help students move from moral outrage to analytical thinking, which is essential in any serious research ethics unit.

Educators can also pair the Lacks case with discussions of archival silences and documentary interpretation. If your students struggle to separate facts from narrative framing, a lesson on how to read historical documents critically can build the habits needed to evaluate consent forms, policy statements, and courtroom settlements. The goal is not simply to memorize what happened, but to understand why the case still shapes legal and ethical debates today.

What the Novartis Settlement Adds to the Conversation

Settlements as signals, not just endings

According to the source report, Novartis settled a lawsuit brought by the Lacks estate alleging unjust profit from cells taken without Henrietta Lacks’ knowledge. In a classroom, that settlement can be discussed as a legal signal: when a company resolves a claim, it may not admit fault, but it acknowledges that the underlying dispute carries enough weight—financial, reputational, and ethical—to require closure. This is a crucial distinction for students learning how law and ethics interact without collapsing into each other.

Settlement also raises a teaching point about remedy. Some cases ask for monetary damages; others ask for transparency, acknowledgment, access to records, or structural reforms. The Lacks story invites students to think beyond a binary of guilty/innocent and toward the broader question of what repair looks like after decades of asymmetry. That is an especially valuable lesson in a world where data, tissue, and algorithmic models can all be sourced from people who may never know their contributions have become monetized assets.

Why profits are ethically relevant

Students often assume that if research produces a cure or improves public health, the moral issue disappears. The Lacks case shows why that is incomplete. Profit matters because it can reveal who bears the costs and who captures the upside. If a patient’s biological material becomes the basis of profitable products, patents, or corporate partnerships, then questions about fairness, recognition, and benefit-sharing become unavoidable. This is where the story moves from tragic history into living policy debate.

For an accessible way to explain this, compare biospecimens to creative work. If someone’s photograph is used in an ad campaign, most students instantly recognize why permission matters. Human tissues are not the same as images, but both can become assets in systems that extract value from a person’s identity or body. That analogy helps students grasp why bioethics cannot be reduced to technical compliance alone. It also connects naturally to lessons on rights, contracts, and attribution, including the legal meaning of consent and how institutions document permissions.

What educators should emphasize

The most productive classroom takeaway is not “science is bad” or “companies are predatory.” It is that large-scale biomedical research needs rules that protect the people who make discovery possible. The Novartis settlement can therefore be used to demonstrate how modern legal disputes often arise from older practices that were normalized at the time. Students should learn to ask whether ethical standards are adequate not only for today’s climate, but for future uses of stored biospecimens and data. That forward-looking view is one of the hallmarks of mature patient rights education.

For more context on structured public-facing explanations of complicated issues, see our guide to classroom-ready historical narratives. It offers strategies for turning emotionally charged material into disciplined inquiry without flattening the human stakes. That is exactly the challenge the Lacks case presents.

One of the biggest misconceptions in medical ethics is that consent is simply a form signed at admission. In reality, informed consent requires that a patient understand the nature of the procedure, the risks, the alternatives, and the likely uses of their contribution. In the Henrietta Lacks case, the ethical issue was not merely that cells were taken; it was that she was not told her tissue would be used in research and would later circulate in vast scientific and commercial networks. That omission is the heart of the matter.

Teachers can use this distinction to show why paperwork alone is not enough. Students should examine examples of generic hospital forms and ask: Would a reasonable person know what happens to biospecimens after collection? Would they understand that de-identified samples can still carry ethical significance? Would they know whether their material could be shared with third parties or used in commercial research? These questions make the concept of informed consent concrete.

Historical context matters

It is also important to explain why 1951 differs from today. Medical norms, civil rights protections, and institutional review processes were far less developed than they are now. That does not excuse the failure, but it helps students understand how ethical standards evolve. A strong curriculum should ask learners to compare historical practice with modern expectations, including privacy rules, research oversight, and institutional review board procedures. If you need a framework for organizing these comparisons, our overview of ethical decision-making in public institutions can help scaffold the lesson.

This is where law enters the picture. Consent obligations are not just moral ideals; they are embedded in regulatory frameworks and institutional policies. The Lacks case can therefore teach students how rights become enforceable over time. It also reveals why patient-facing explanations must be understandable, culturally competent, and honest about downstream uses. In short, consent must be informed, not just documented.

Classroom activity idea

Ask students to rewrite a fictional tissue-consent form in plain language. Include questions about future research, commercialization, data sharing, and withdrawal rights. Then have students compare their version with a standard hospital form and identify where ambiguity remains. This exercise works particularly well in civics, biology, and health classes because it shows how language itself can either protect or obscure rights. To deepen the lesson, pair it with our resource on public records and documentary evidence, which reinforces the habit of reading institutional language critically.

Biospecimens, Ownership, and the Limits of “Your Body, Your Property”

What is a biospecimen?

A biospecimen is any biological sample taken from a person for diagnosis, treatment, or research—blood, tissue, saliva, DNA, and more. Students should know that once removed from the body, these materials often enter a network of storage, testing, sharing, and analysis. The ethical question is not simply whether a sample belongs to the person forever, but what rights remain attached to it after collection. That is why the Lacks case continues to matter: it exposes the gap between bodily autonomy and sample governance.

For classroom purposes, biospecimens are a useful bridge between science and law. They allow students to see that materials can have both medical and economic value. A specimen can contribute to a diagnosis, a study, a patent, a product line, or a database. When those uses are opaque, trust erodes. This is one reason modern research institutions devote so much attention to transparency, traceability, and oversight.

Ownership is legally complicated

Many students assume that if a tissue sample comes from your body, you must own it in the same way you own a phone or a backpack. But the law is more complicated. Courts have often distinguished between control, privacy, and property rights. In practical terms, this means that a patient may have meaningful interests in how samples are collected and used without having full property rights over the sample itself. The distinction is subtle, but it is essential for understanding why the Lacks case became such a landmark.

A classroom discussion can use this tension to introduce legal nuance. Ask students to consider whether a property-rights model would solve the problem, or whether it might create new obstacles for public health research. Then ask whether a stronger consent-and-benefit-sharing model could better protect patient rights without stopping scientific progress. This is the sort of tradeoff analysis that makes a bioethics curriculum genuinely rigorous.

Benefit-sharing as an ethical reform

Not every ethical solution has to involve direct payment, but benefit-sharing is increasingly part of the conversation. Benefit-sharing can include acknowledgment, access to findings, community investment, protections against misuse, or a voice in governance. The Lacks case illustrates why “we used your sample for the common good” is not sufficient when the common good is built on someone else’s unrecognized contribution. Students should understand that fairness may require more than gratitude; it may require structure.

If your students need a simple comparison, think of a table of rights, risks, and remedies. The line between medical use and commercial use is often where ethical scrutiny intensifies. Our guide on contract clauses and institutional accountability can help students connect these ideas to broader governance questions. Once they see that tissue use is governed by systems, not just intentions, the Lacks story becomes much easier to analyze.

How to Teach the Case: A Classroom-Ready Framework

Start with the human story

Students engage more deeply when they first understand Henrietta Lacks as a person, not just as a source of cells. Introduce her life, her illness, the hospital context, and the family’s later experience. This creates the emotional and historical grounding needed for serious ethical reflection. It also prevents the case from becoming a sterile compliance exercise.

A good teacher will resist reducing the lesson to a single moral verdict. Instead, students should be guided to trace the layers of the case: race, class, medical authority, research practices, family impact, and public memory. A similar approach is used in our piece on crafting compelling narratives from complicated contexts, which can be especially helpful for educators seeking to balance empathy and analysis. In the Lacks case, the narrative matters because it is the vehicle through which ethical reasoning becomes memorable.

Move from story to systems

Once students know the human dimension, shift to institutions. Who collected the tissue? What norms governed tissue research in the 1950s? How do hospitals, universities, and corporations today manage sample use? This systems approach helps students see that ethical failures often emerge from routine practices rather than isolated bad acts. That insight is important because it prevents simplistic blame and encourages policy thinking.

To make systems visible, students can map the life cycle of a biospecimen from collection to storage to research use to commercialization. They can identify where consent is obtained, where oversight occurs, and where transparency tends to break down. This is a great opportunity to compare historical practices with modern governance mechanisms. If your class is also studying source evaluation, our guide to archival research methods offers a useful companion framework.

Use debate, but keep it structured

Debate is effective here, but it must be structured carefully. Assign roles such as patient advocate, hospital administrator, researcher, regulator, and family member. Require each group to cite ethical principles—autonomy, beneficence, justice, and transparency—rather than rely on emotional rhetoric alone. This creates a disciplined conversation that mirrors real policy disagreements.

Students can also write short position papers answering a practical question: Should institutions share profits from products derived from human biospecimens? Why or why not? Their answers will reveal whether they understand the distinction between moral admiration, legal ownership, and fair compensation. For examples of how to turn complex issues into student-facing materials, see our article on building classroom-ready explanations of public controversy.

Modern Ethics Reforms: What Changed After Cases Like Lacks?

Institutional review and oversight

One of the biggest reforms in research ethics has been the rise of formal oversight structures, including institutional review boards and stronger review standards for human-subject research. These mechanisms are designed to ensure that risk is justified, consent is meaningful, and vulnerable populations receive special protection. While no system is perfect, the modern research environment is vastly more attentive to ethics than the one in which HeLa cells first entered circulation. That historical contrast is one reason the case remains pedagogically essential.

Students should understand that oversight is not a bureaucratic nuisance; it is a hard-won response to past harm. The same applies to data governance, tissue banks, and secondary use policies. Our guide on how institutions document permission and use rights can help contextualize these reforms as part of a broader accountability ecosystem. This allows educators to show how law, policy, and professional norms reinforce one another.

Privacy, de-identification, and their limits

Today, researchers often rely on de-identified samples, but de-identification is not a magic wand. Biological materials can sometimes be re-linked to individuals, and even when they cannot, communities may still have ethical concerns about how samples are used. The Lacks case has helped push the field toward more careful thinking about privacy, consent, and community trust. That is a useful lesson for students living in an age when biological, digital, and genetic data are all increasingly interconnected.

In class, it is helpful to emphasize that privacy protections must evolve alongside technology. As analytics become more powerful, old assumptions about anonymous data weaken. Students can compare the logic of tissue governance with the logic of digital footprints and data sharing, especially if they have studied document interpretation and evidence chains. The parallel is clear: once information moves through institutions, control becomes more complicated, and accountability more important.

Equity and representation

The Lacks story also reminds us that ethics is not only about consent but about justice. Communities that have historically been exploited in medicine may reasonably distrust institutions that ask for samples without offering transparency or reciprocity. Modern ethics reforms increasingly stress inclusion, community engagement, and culturally responsive communication. That shift is important because trust is not a public-relations slogan; it is a precondition for responsible research.

Teachers can ask students why trust matters so much in medicine compared with many other fields. The answer is that patients are vulnerable, information is asymmetric, and the consequences of abuse can be profound and lasting. A research ethics curriculum that ignores inequity misses the point. For a broader framework on teaching difficult historical material responsibly, see our guide to narrative ethics in the classroom.

Data and Comparison: How the Ethics Conversation Has Evolved

Below is a comparison table educators can use to help students distinguish historical practice from modern expectations. It is intentionally simplified for teaching, but it highlights the key points that make the Henrietta Lacks case so durable in the public imagination.

Issue1951 ContextModern ExpectationTeaching Takeaway
Informed consentMinimal disclosure; tissue taken without meaningful explanationClear, plain-language disclosure of uses, risks, and alternativesConsent must be informed, not assumed
Biospecimen useSamples could be propagated and shared with little oversightGoverned by review, policy, and documentationSample governance is now a formal ethical concern
Profit and commercializationBenefits flowed largely to institutions and downstream usersBenefit-sharing and disclosure increasingly debatedValue creation raises fairness questions
Patient communicationFamily often excluded from explanations and decisionsGreater emphasis on transparency and respectEthics includes communication, not just procedure
Legal remediesLimited pathways for recognition or redressLitigation, settlements, policy reform, and institutional apologyLaw can respond, but often after harm has occurred

This table can be used as a worksheet, a slide, or a discussion prompt. Students can fill in a sixth row on their own, such as “community trust,” “data privacy,” or “family rights.” That active extension makes the lesson more durable. It also reinforces the idea that ethical history is not closed; it keeps evolving with each new dispute and reform.

Pro Tip: When teaching the Lacks case, ask students to identify the difference between legal permission, ethical legitimacy, and public trust. Those three things often overlap, but they are not the same.

Lesson Design: A 50-Minute Classroom Plan

Opening: hook and framing

Begin with a short paragraph or image-based prompt about HeLa cells and ask students what they think the source of the cells was. Most will know the science before they know the story, which is exactly why this lesson works. Then reveal Henrietta Lacks’ identity and ask whether scientific fame changes the ethical analysis. This contrast between discovery and disclosure creates immediate engagement.

Next, introduce the Novartis settlement as the modern anchor. Explain that the case is not just about the past; it is about how current companies and institutions continue to confront the legacy of older research practices. That helps students see that ethics is not a museum piece. It is a live issue in health law, medical history, and policy.

Middle: source analysis and guided discussion

Have students read a short summary of the case and annotate for three categories: facts, ethical concerns, and unanswered questions. Then ask them to identify where the estate’s claim fits into those categories. This teaches them to separate what is known from what is argued, a skill that matters in any serious reading of public controversy. If you want to strengthen source analysis, pair this activity with our guide to evaluating public claims using documentary evidence.

After annotation, divide the class into small groups and have each group discuss one question: Who should control biospecimens? Who should profit? What should institutions owe patients after the fact? Each group should report back with one principle and one policy recommendation. That structure keeps the discussion from becoming vague or overly emotional.

Closing: reflection and assessment

End with a short reflective writing prompt: “What should a just research system owe the people whose bodies make discovery possible?” This question pushes students to synthesize history, law, and ethics. You can also ask them to propose one reform they think would make research more trustworthy. Their responses will show whether they understand the difference between symbolic acknowledgment and structural change.

For teachers who want to expand the lesson into a multi-day unit, connect it to a unit on public memory, archival silence, and the politics of medical innovation. Our article on teaching complicated stories in accessible ways can help with pacing and framing. The Henrietta Lacks case is rich enough to support both a single lesson and an extended seminar.

FAQ: Henrietta Lacks, Research Ethics, and Patient Rights

What is the main ethical issue in the Henrietta Lacks case?

The central issue is that cells from Henrietta Lacks’ tumor were taken and used for research without her knowledge or meaningful consent. The case raises broader concerns about patient autonomy, fairness, and the use of human biological materials for scientific and commercial gain.

Why does the Novartis settlement matter?

The settlement matters because it shows the legal and ethical questions surrounding HeLa cells are still active. It signals that companies benefiting from biospecimens may face scrutiny over whether profit was built on an unjust historical process.

Did Henrietta Lacks own her cells?

That is a complex legal question. In many jurisdictions, the law does not treat removed tissue the same way it treats ordinary personal property. However, the case clearly demonstrates that patients retain important rights and interests in how their tissues are collected and used.

How can teachers explain informed consent simply?

A useful explanation is that informed consent means a person understands what is being done, why it is being done, what the risks and alternatives are, and how their tissue or data may be used afterward. A signature alone is not enough if the person did not truly understand the terms.

What modern reforms came from cases like this?

Modern reforms include stronger institutional review, clearer consent standards, better privacy protections, and more attention to transparency and community trust. These reforms help reduce the chance that research benefits will be built on hidden or unfair practices.

Conclusion: Why This Case Belongs in Every Bioethics Curriculum

The Henrietta Lacks story remains essential because it sits at the center of a question every student should learn to ask: What do institutions owe the people who make knowledge possible? The answer includes more than scientific progress. It includes honesty, consent, respect, oversight, and, when appropriate, restitution. The Novartis settlement makes that lesson newly urgent because it demonstrates that the moral and legal effects of old research practices still shape the present.

For educators, this case is a high-value teaching tool precisely because it connects so many domains: medical history, law, race, public policy, and ethics. It is also an ideal entry point into broader discussions of patient rights, governance, and the responsibilities of research institutions. If your students can understand why Henrietta Lacks’ story matters, they are already learning how to think like ethical citizens. For continued reading, explore our resources on primary sources and historical accountability, research ethics in practice, and classroom-ready civics materials.

Advertisement

Related Topics

#Bioethics#Medical History#Legal Ethics
D

Dr. Eleanor Grant

Senior Editor and Research Ethics Writer

Senior editor and content strategist. Writing about technology, design, and the future of digital media. Follow along for deep dives into the industry's moving parts.

Advertisement
2026-04-17T01:52:11.165Z